Study

EORTC-10085-BCG

Clinical and biological characterization of Male Breast Cancer : an international retrospective EORTC, BIG and NABCG intergroup study (for the prospective part, please refer to 10085p)

Study documentation Back to result

Trial Status

LT-FU ongoing

Dates

Date of activation: 27-Dec-2010
Date Step1 close: 03-Sep-2013

Data management at EORTC

Yes

Design

Cohort
Randomized open label

Targeted Sample size

EORTC Groups: 1800 - All Groups: 1800

Study Staff

  • Fatima Cardoso (Study Coordinator), Champalimaud Clinical Center, Lisboa
  • Sharon Hermes Giordano (Study Coordinator), M D Anderson Cancer Center, Houston
  • Melanie Beauvois (Clinical Operations Manager), EORTC Headquarters, Brussels
  • Ruxandra Dionisie (Pharmacovigilance Manager), EORTC Headquarters, Brussels
  • Sandrine Marreaud (Clinical Research Physician), EORTC Headquarters, Brussels
  • Coralie Poncet (Statistician), EORTC Headquarters, Brussels
  • Sandrine Rivrain (Pharmacovigilance Manager), EORTC Headquarters, Brussels

Type of cancer

  • Breast

Participating groups

  • EORTC Breast Cancer Group
  • Swedish Association of Breast Oncologists
  • Breast International Group
  • Schweizerisches Arbeitsgemeinschaft Klin. Krebsforschung
  • Borstkanker Onderzoek Group Nederland
  • Cancer Trials Ireland

Recruiting centers

  • AZ Damiaan (Oostende, Belgium)
  • AZ Groeninge – Oncology Centre (Kortrijk, Belgium)
  • CHU Helora Pole Hospitalier Jolimont - Hopital Jolimont (Haine-Saint-Paul, Belgium)
  • CHU Site Sainte-Elisabeth-UCL Namur (Namur, Belgium)
  • Centre Hospitalier Universitaire Vaudois - Lausanne (Lausanne, Switzerland)
  • Cliniques Universitaires Saint-Luc (Brussels, Belgium)
  • Cork University Hospital (Cork, Ireland)
  • Dana-Farber/Harvard Cancer Center (Boston, United States of America)
  • Eastbourne District General Hospital (Eastbourne, United Kingdom)
  • Fred Hutchinson Cancer Center (Seattle, United States of America)
  • Hopital du Valais - Hopital de Sion (Sion, Switzerland)
  • Hospital Universitari Vall d’Hebron -Vall d'Hebron Institut Oncologia (Barcelona, Spain)
  • Inselspital (Bern, Switzerland)
  • Institut Jules Bordet (Anderlecht, Belgium)
  • Kantonsspital Baden (Baden, Switzerland)
  • Kantonsspital Baselland - Bruderholz (Bruderholz, Switzerland)
  • Kantonsspital Baselland - Liestal (Liestal, Switzerland)
  • Kantonsspital St Gallen (St Gallen, Switzerland)
  • Kantonsspital Winterthur (Winterthur, Switzerland)
  • Luzerner Kantonsspital (Luzern, Switzerland)
  • M D Anderson Cancer Center (Houston, United States of America)
  • Mater Misericordia University Hospital (Dublin, Ireland)
  • Medical University Of Gdansk (Gdansk, Poland)
  • Memorial Sloan-Kettering Cancer Center - Memorial hospital (New York, United States of America)
  • NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre - Gartnavel General Hospital (Glasgow, United Kingdom)
  • NHS Lothian - Western General Hospital (Edinburgh, United Kingdom)
  • North Tees and Hartlepool NHS Foundation Trust - University Hospital of North Tees (Stockton on Tees, United Kingdom)
  • Oncology Institute of Southern Switzerland - Ospedale Beata Vergine (Mendrisio, Switzerland)
  • Royal Sussex County Hospital (Brighton, United Kingdom)
  • Sonnenhofklinik Engeriedspital (Bern, Switzerland)
  • Spitalzentrum Biel (Biel, Switzerland)
  • St. Claraspital (Basel, Switzerland)
  • St. James'S Hospital (Dublin, Ireland)
  • St. Vincent'S University Hospital (Dublin 4, Ireland)
  • Tumor- und BrustZentrum Ostschweiz (St Gallen, Switzerland)
  • U.Z. Leuven - Campus Gasthuisberg (Leuven, Belgium)
  • UniversitaetsSpital Zurich (Zurich, Switzerland)
  • Universitaetsspital Basel (Basel, Switzerland)
  • Universitair Ziekenhuis Antwerpen (Edegem, Belgium)
  • University Hospital Waterford (Waterford, Ireland)
  • Worthing Hospital (Worthing - West Sussex, United Kingdom)
  • ZAS Middelheim (Antwerpen, Belgium)
  • ZAS Palfijn (Merksem, Belgium)

Centers to be activated

  • Mid Cheshire Hospitals NHS Foundation Trust - Leighton Hospital (Crewe, United Kingdom)
  • Radio-Onkologie Berner Oberland AG (Thun, Switzerland)

Protocol summary

http://clinicaltrials.gov/study/NCT01101425

NCT number

NCT01101425